News & Updates

Psychedelic drugs show promise for anxiety, depression
Psychedelic drugs show promise for anxiety, depression
08 Jun 2023
Is liposomal irinotecan superior to topotecan in relapsed small cell lung cancer?
Is liposomal irinotecan superior to topotecan in relapsed small cell lung cancer?
07 Jun 2023 byStephen Padilla

Treatment with liposomal irinotecan in adults with relapsed small cell lung cancer (SCLC) achieves similar overall survival (OS) when compared with topotecan, but the former is associated with a higher overall response rate (ORR), according to the results of RESILIENT, randomized, open-label phase III trial.

Is liposomal irinotecan superior to topotecan in relapsed small cell lung cancer?
07 Jun 2023
T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
07 Jun 2023 byNatalia Reoutova

A retrospective observational study of nearly 28,000 patients with type 2 diabetes mellitus (T2DM) in Hong Kong finds that use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is independently associated with lower rates of ICU admission and all-cause mortality across various disease categories.

T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
07 Jun 2023